Form D — Sensorium Therapeutics, Inc.
0001874823-25-000001 · filed 2025-02-12
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $38,496,525
- Total sold
- $14,496,526
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Sensorium Therapeutics, Inc.
- CIK
- 1874823
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2021
- Address
- 40 GUEST STREET
BOSTON, MA 02136 - Phone
- (562) 688-5433
Related persons
-
Alexandra Glucksmann · Executive OfficerBoston, MA
-
Richard Simon · DirectorBoston, MA
-
Jerrold Rosenbaum · DirectorBoston, MA
-
Kevin Lalande · DirectorBoston, MA
-
Ryan Katz · DirectorBoston, MA
-
David Southwell · DirectorBoston, MA
-
Balkrishan Gill · DirectorBoston, MA
View original on SEC EDGAR.